Portugal
The company has acquired extensive experience over its approximately 50 years in the market, enabling it to not only produce its own brands but also manufacture and market licensed products in partnership with major global pharmaceutical companies. Medinfar continuously invests in new therapeutic areas and expanding its product portfolio. Additionally, a key aspect of the business strategy is internationalization, with a presence in over 40 countries, notably in Morocco where it has a subsidiary, as well as distribution in various regions worldwide, including Europe, Francophone Africa, PALOP, Middle East, CIS (former USSR), and Asia.
As of now, there is no available information on the last investment or the involved investors in Medinfar. The company operates in the Biotechnology, Manufacturing, and Pharmaceutical industries from its base in Portugal.
